BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6899978)

  • 1. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
    Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
    Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
    [No Abstract]   [Full Text] [Related]  

  • 2. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and quantitation of the components of the alternative complement pathway.
    Minta JO; Gee AP
    Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation and function of the classical and alternative pathways of complement.
    Ogle JD; Ogle CK
    Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative pathway of complement.
    Pangburn MK
    Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.
    Michaels DW; Abramovitz AS; Hammer CH; Mayer MM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2852-6. PubMed ID: 1066698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
    Kitamura H; Matsumoto M; Nagaki K
    Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.
    Guc D; Gulati P; Lemercier C; Lappin D; Birnie GD; Whaley K
    Rheumatol Int; 1993; 13(4):139-46. PubMed ID: 8310205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of C5 convertase activity by properdin, factors B and H.
    Weiler JM
    Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 12. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement.
    Esser AF; Sodetz JM
    Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325
    [No Abstract]   [Full Text] [Related]  

  • 16. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
    Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1978 Dec; 148(6):1722-7. PubMed ID: 722244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
    Spitzer R; Stitzel A; Florio L; Urmson J
    Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
    [No Abstract]   [Full Text] [Related]  

  • 18. [The alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliment system proteins: properties and biological activity (Lecture)].
    Kashkin KP; Dmitrieva LN
    Klin Lab Diagn; 2000 Jul; (7):25-32. PubMed ID: 10981394
    [No Abstract]   [Full Text] [Related]  

  • 20. Large scale isolation of functionally active components of the human complement system.
    Hammer CH; Wirtz GH; Renfer L; Gresham HD; Tack BF
    J Biol Chem; 1981 Apr; 256(8):3995-4006. PubMed ID: 6783652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.